Literature DB >> 25376811

Comparison of 3T and 7T susceptibility-weighted angiography of the substantia nigra in diagnosing Parkinson disease.

M Cosottini1, D Frosini2, I Pesaresi3, G Donatelli4, P Cecchi3, M Costagli5, L Biagi6, R Ceravolo2, U Bonuccelli2, M Tosetti6.   

Abstract

BACKGROUND AND
PURPOSE: Standard neuroimaging fails in defining the anatomy of the substantia nigra and has a marginal role in the diagnosis of Parkinson disease. Recently 7T MR target imaging of the substantia nigra has been useful in diagnosing Parkinson disease. We performed a comparative study to evaluate whether susceptibility-weighted angiography can diagnose Parkinson disease with a 3T scanner.
MATERIALS AND METHODS: Fourteen patients with Parkinson disease and 13 healthy subjects underwent MR imaging examination at 3T and 7T by using susceptibility-weighted angiography. Two expert blinded observers and 1 neuroradiology fellow evaluated the 3T and 7T images of the sample to identify substantia nigra abnormalities indicative of Parkinson disease. Diagnostic accuracy and intra- and interobserver agreement were calculated separately for 3T and 7T acquisitions.
RESULTS: Susceptibility-weighted angiography 7T MR imaging can diagnose Parkinson disease with a mean sensitivity of 93%, specificity of 100%, and diagnostic accuracy of 96%. 3T MR imaging diagnosed Parkinson disease with a mean sensitivity of 79%, specificity of 94%, and diagnostic accuracy of 86%. Intraobserver and interobserver agreement was excellent at 7T. At 3T, intraobserver agreement was excellent for experts, and interobserver agreement ranged between good and excellent. The less expert reader obtained a diagnostic accuracy of 89% at 3T.
CONCLUSIONS: Susceptibility-weighted angiography images obtained at 3T and 7T differentiate controls from patients with Parkinson disease with a higher diagnostic accuracy at 7T. The capability of 3T in diagnosing Parkinson disease might encourage its use in clinical practice. The use of the more accurate 7T should be supported by a dedicated cost-effectiveness study.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2014        PMID: 25376811      PMCID: PMC8013050          DOI: 10.3174/ajnr.A4158

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  38 in total

1.  The substantia nigra in Parkinson disease: proton density-weighted spin-echo and fast short inversion time inversion-recovery MR findings.

Authors:  Hirobumi Oikawa; Makoto Sasaki; Yoshiharu Tamakawa; Shigeru Ehara; Koujiro Tohyama
Journal:  AJNR Am J Neuroradiol       Date:  2002 Nov-Dec       Impact factor: 3.825

2.  Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.

Authors:  Makoto Sasaki; Eri Shibata; Koujiro Tohyama; Junko Takahashi; Kotaro Otsuka; Kuniaki Tsuchiya; Satoshi Takahashi; Shigeru Ehara; Yasuo Terayama; Akio Sakai
Journal:  Neuroreport       Date:  2006-07-31       Impact factor: 1.837

Review 3.  EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Authors:  A Berardelli; G K Wenning; A Antonini; D Berg; B R Bloem; V Bonifati; D Brooks; D J Burn; C Colosimo; A Fanciulli; J Ferreira; T Gasser; F Grandas; P Kanovsky; V Kostic; J Kulisevsky; W Oertel; W Poewe; J-P Reese; M Relja; E Ruzicka; A Schrag; K Seppi; P Taba; M Vidailhet
Journal:  Eur J Neurol       Date:  2013-01       Impact factor: 6.089

4.  The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service.

Authors:  Andrew J Hughes; Susan E Daniel; Yoav Ben-Shlomo; Andrew J Lees
Journal:  Brain       Date:  2002-04       Impact factor: 13.501

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 6.  Imaging of the aging brain. Part II. Pathologic conditions.

Authors:  B P Drayer
Journal:  Radiology       Date:  1988-03       Impact factor: 11.105

7.  Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland.

Authors:  Edward J Newman; Kieran Breen; Jim Patterson; Donald M Hadley; Katherine A Grosset; Donald G Grosset
Journal:  Mov Disord       Date:  2009-12-15       Impact factor: 10.338

8.  Differentiation between Parkinson disease and other forms of Parkinsonism using support vector machine analysis of susceptibility-weighted imaging (SWI): initial results.

Authors:  S Haller; S Badoud; D Nguyen; I Barnaure; M-L Montandon; K-O Lovblad; P R Burkhard
Journal:  Eur Radiol       Date:  2012-07-15       Impact factor: 5.315

9.  MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM).

Authors:  Michael Hutchinson; Ulrich Raff; Sergey Lebedev
Journal:  Neuroimage       Date:  2003-11       Impact factor: 6.556

10.  Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.

Authors:  Anna I Blazejewska; Stefan T Schwarz; Alain Pitiot; Mary C Stephenson; James Lowe; Nin Bajaj; Richard W Bowtell; Dorothee P Auer; Penny A Gowland
Journal:  Neurology       Date:  2013-07-10       Impact factor: 9.910

View more
  37 in total

1.  Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.

Authors:  Albert Stezin; Rajini M Naduthota; Ragasudha Botta; Shriram Varadharajan; Abhishek Lenka; Jitender Saini; Ravi Yadav; Pramod Kumar Pal
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Signal Alteration of Substantia Nigra on 3.0T Susceptibility-weighted Imaging in Parkinson's Disease and Vascular Parkinsonism.

Authors:  Xue-Jun Zhao; Xi-Yuan Niu; He-Yang You; Min Zhou; Xue-Bing Ji; Ying Liu; Lei Wu; Xiao-Ling Ding
Journal:  Curr Med Sci       Date:  2019-10-14

Review 3.  Perspectives of Ultra-High-Field MRI in Neuroradiology.

Authors:  E R Gizewski; C Mönninghoff; M Forsting
Journal:  Clin Neuroradiol       Date:  2015-07-17       Impact factor: 3.649

Review 4.  Nigrosome 1 imaging: technical considerations and clinical applications.

Authors:  Eung Yeop Kim; Young Hee Sung; Jongho Lee
Journal:  Br J Radiol       Date:  2019-06-05       Impact factor: 3.039

5.  Nigrosome 1 Detection at 3T MRI for the Diagnosis of Early-Stage Idiopathic Parkinson Disease: Assessment of Diagnostic Accuracy and Agreement on Imaging Asymmetry and Clinical Laterality.

Authors:  Y Noh; Y H Sung; J Lee; E Y Kim
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

6.  Visualization of Nigrosome 1 from the Viewpoint of Anatomic Structure.

Authors:  N Arai; H Kan; M Ogawa; Y Uchida; M Takizawa; K Omori; T Miyati; H Kasai; H Kunitomo; Y Shibamoto
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-05       Impact factor: 3.825

7.  Reply.

Authors:  N Arai; H Kan
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-05       Impact factor: 3.825

8.  Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.

Authors:  Manuel S Perez Akly; Carla V Stefani; Lucía Ciancaglini; José S Bestoso; Jorge A Funes; Diego J Bauso; Cristina H Besada
Journal:  Neuroradiol J       Date:  2019-05-31

Review 9.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 10.  Role of Neuroimaging on Differentiation of Parkinson's Disease and Its Related Diseases.

Authors:  Toshihide Ogawa; Shinya Fujii; Keita Kuya; Shin-Ichiro Kitao; Yuki Shinohara; Mana Ishibashi; Yoshio Tanabe
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.